Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03498560 · ClinicalTrials.gov registry record

Examining the Association Between Pre-existing Sleep Disturbance and Postoperative Delirium

A clinical trial of Delirium, sponsored by Massachusetts General Hospital.

Completed
Registry status
38
Enrollment target
1
Study location

NCT03498560: Completed study of Delirium, sponsored by Massachusetts General Hospital.

NCT03498560 is a study of Delirium that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03498560, a study of Delirium, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
38 participants
Enrollment target
1
Study location

Study Summary

The investigators are performing this research study to understand the role of sleep disturbance on the incidence/severity of delirium after surgery. The investigators will study the brain using a polysomnography device (PSG), which records the brain's electrical activity during sleep.

Conditions Studied

Interventions

  • DEVICE PSG

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2018-11-01
Est. Completion 2019-09-01

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03498560

The ClinicalTrials.gov registry entry for NCT03498560 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (96% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which PSG is the first listed.

NCT03498560 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03498560 about?

NCT03498560 is a clinical study titled "Examining the Association Between Pre-existing Sleep Disturbance and Postoperative Delirium". The investigators are performing this research study to understand the role of sleep disturbance on the incidence/severity of delirium after surgery. The investigators will study the brain using a polysomnography device (PSG), which records the brain's electrical activity during sleep.

What is the current status of trial NCT03498560?

This trial is currently completed. The enrollment target is 38 participants. The study started on 2018-11-01. Estimated completion is 2019-09-01.

What conditions does trial NCT03498560 study?

This clinical trial studies the following conditions: Delirium.

What interventions are being tested in trial NCT03498560?

The interventions under investigation include: PSG (DEVICE).

Who is sponsoring clinical trial NCT03498560?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03498560 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.